ScanSource (SCSC) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Jan, 2026Executive summary
Accelerated adoption of a hybrid distribution strategy and focus on high-growth partners, AI, and private 5G are expanding the total addressable market.
Two high-margin, recurring revenue acquisitions—Resorsive/Resourcive and Advantix—were completed to support the hybrid strategy and expand integrated solutions.
Leadership changes include the appointment of Ken Mills as President of Intelisys to drive channel growth.
Fiscal year 2024 net sales declined 13.9% year-over-year to $3.26 billion amid a soft demand environment, but gross margin improved to 12.2% from 11.9% due to higher Intelisys revenue mix.
Strong cash generation with $371.6 million in operating cash flow and $363.1 million in free cash flow for the year.
Financial highlights
FY 2024 net sales declined 13.9% year-over-year to $3.26 billion; gross profit margin improved to 12.2%.
GAAP net income declined 12.5% to $77.1 million; non-GAAP net income declined 20.5%; non-GAAP EPS was $3.08, down from $3.85.
Free cash flow for FY 2024 was $363 million, driven by working capital efficiency improvements.
Q4 FY24 net sales dropped 21.2% year-over-year to $746.1 million; gross profit margin rose to 13.04%.
Adjusted EBITDA for FY24 was $140.7 million (4.31% margin), down 21.8% year-over-year.
Outlook and guidance
FY 2025 net sales are expected between $3.1 billion and $3.5 billion, with adjusted EBITDA of $140–$160 million and margins of 4.5%–4.6%.
Free cash flow for FY 2025 is projected at a minimum of $70 million, reflecting the completion of major working capital reductions.
Guidance excludes potential impacts from future acquisitions or significant transactions.
The demand environment is expected to remain challenging in the near term, especially in H1 FY 2025.
Latest events from ScanSource
- Recurring revenues and disciplined capital allocation drive margin growth and efficiency.SCSC
47th Annual Raymond James Institutional Investor Conference5 Mar 2026 - Q2 FY26 sales grew 2.5%, but margin pressure led to reduced full-year guidance.SCSC
Q2 20265 Feb 2026 - Recurring revenue and margin gains offset sales decline; FY25 outlook reaffirmed.SCSC
Q1 202515 Jan 2026 - Hybrid distribution and recurring revenue drive growth, with a focus on cash flow and strategic M&A.SCSC
Raymond James 2024 TMT & Consumer Conference11 Jan 2026 - Sales fell 15.5% but margin and recurring revenue rose; FY25 guidance reaffirmed.SCSC
Q2 20259 Jan 2026 - Recurring revenue now exceeds 30% of gross profit, fueling margin expansion and strategic growth.SCSC
Raymond James & Associates’ 46th Annual Institutional Investors Conference 202514 Dec 2025 - Transformation to a converged hardware and recurring revenue model drives growth and margin expansion.SCSC
Raymond James TMT and Consumer Conference10 Dec 2025 - Shareholders to vote on directors, executive pay, auditor, and new incentive plan amid strong cash flow.SCSC
Proxy Filing1 Dec 2025 - Strong cash flow, margin growth, and governance focus highlight FY2025, with key votes ahead.SCSC
Proxy Filing1 Dec 2025